Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cassard, S.
Right arrow Articles by Bonnerot, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cassard, S.
Right arrow Articles by Bonnerot, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 39, Issue of September 27, 1996 pp. 23786-23791
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Regulation of ITAM Signaling by Specific Sequences in Ig-beta B Cell Antigen Receptor Subunit*

(Received for publication, May 3, 1996)

Sylvanie Cassard Dagger §, Daniel Choquet par '', Wolf Herman Fridman ''' and Christian Bonnerot Dagger

From Dagger  CJF 95-01, INSERM, Institut Curie, 75231 Paris cedex 05, par  Unité 261, INSERM, Institut Pasteur, Paris, and ''' Unité 255, INSERM, Institut Curie, 75231 Paris cedex 05, France

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

B cell antigen receptors (BCR) are composed of an antigen binding subunit, the membrane Ig, and Ig-alpha /Ig-beta heterodimers, that contain a transducing motif named ITAM for ``immuno-receptor tyrosine-based activation motif.'' Ig-alpha and Ig-beta ITAMs only differ by four amino acids located before the second conserved tyrosine (DCSM in Ig-alpha and QTAT in Ig-beta ), which determine the in vitro association of Ig-alpha with the src kinase fyn. We have previously shown that Ig-alpha and Ig-beta BCR subunits activate different signaling pathways by expressing, in B cells, Fcgamma RII chimeras containing the cytoplasmic tails of Ig-alpha or Ig-beta . We report here that the signaling capacity of Ig-beta ITAM is regulated by peptide sequences located inside (QTAT region) or outside the ITAM (flanking sequences). Furthermore, when isolated, Ig-alpha and Ig-beta ITAM have similar abilities as the entire Ig-alpha tail and the whole BCR in triggering tyrosine kinase activation, an increase of intracellular calcium concentration as well as late events of cell activation as assessed by cytokine secretion. These data show that alterations that modify the ability of Ig-alpha and Ig-beta to interact in vitro with the src kinase fyn (switch between QTAT and DCSM) also determine signal transduction capabilities of these molecules expressed in B cells.


INTRODUCTION

The transducing capacities of BCR1 are based on its multimolecular structure. BCRs are composed of antigen binding units, the membrane immunoglobulins (mIg), noncovalently associated with transducing subunits, the Ig-alpha /Ig-beta heterodimers. The cytoplasmic tails of these associated chains become phosphorylated after cross-linking of mIg (1) and associate with intracellular effectors (2) including the src kinases lyn, fyn, blk, lck (3, 4, 5, 6), and the src-related kinase syk (7, 8), as well as other kinases such as PI-3 kinase and unidentified phosphoproteins (9). By adsorbing B cell lysates on fusion proteins containing the cytoplasmic domains of Ig-alpha or Ig-beta , the unphosphorylated cytoplasmic domains were shown to bind to different kinases. The cytoplasmic tail of Ig-alpha interact with fyn and lyn and with an unidentified molecule of 38 kDa, whereas the cytoplasmic tail of Ig-beta binds to two unidentified phosphoproteins of 40 and 42 kDa (9). The activation of tyrosine kinase is followed by an increase of intracellular calcium concentration (10). Typical cytoplasmic calcium increase includes an initial release of calcium from intracellular stores followed by an influx of extracellular calcium, which is involved in lymphocytes activation (11, 12). However, both cytoplasmic domains of Ig-alpha and Ig-beta , like associated subunits of T cell antigen receptors or Fc receptors, contain an ITAM (immunoreceptor tyrosine-based activation motif), which contains conserved tyrosine and leucine or isoleucine amino acids (YXX(L/I)XXXXXXXYXX(L/I)) (13). One particularity of Ig-alpha and Ig-beta ITAMs is their high homology because they mostly differ by the four amino acids located before the second conserved tyrosine, the same four residues determining the in vitro association of Ig-alpha with fyn (14).

Functional analysis of Ig-alpha and Ig-beta cytoplasmic domains in B cells established that both are able to induce an increase of intracellular calcium concentration (15, 16, 17) with qualitative differences (18). Although Ig-beta was as efficient as Ig-alpha in triggering protein-tyrosine kinase activation, only Ig-alpha -containing chimeras were able to trigger an efficient signal transduction leading to an extracellular calcium influx and interleukin-2 (IL-2) production in the IIA1.6 B cell line. Ig-beta triggered an oscillatory release from intracellular calcium stores and no IL-2 secretion (18). Ig-alpha and Ig-beta cytoplasmic domains therefore possess their own distinct signaling capabilities. In this study, the molecular basis of the different signaling capacities of Ig-alpha and Ig-beta cytoplasmic tails were analyzed. We showed that BCR subunits transducing activities are based on the ITAM conserved sequence, but they may be regulated by unconserved sequences located inside or outside the motif.


MATERIALS AND METHODS

Plasmid Construction

Ig-alpha and Ig-beta chimeras were constructed by adding the sequences encoding the putative cytoplasmic domains of Ig-alpha and Ig-beta to the extracellular and transmembrane domains of cDNA encoding mouse Fcgamma RII (FcR) by recombinant polymerase chain reaction as described previously (18). Site-directed mutagenesis of the Ig-alpha and Ig-beta chimeras was also performed using polymerase chain reaction. The resulting constructions were inserted in SRalpha -driven expression vector and then were sequenced.

Cell Culture and Transfection

The B lymphoma IIA1.6 is a Fcgamma R-defective variant of A20 B cells that grows in RPMI 1640 containing 10% fetal calf serum, 10 mM glutamine, 100 units/ml penicillin, 100 µg/ml streptomycin, 50 µM 2-mercaptoethanol, and 5 mM sodium pyruvate (Life Technologies, Inc.). These cells express endogenous mIgG2a. The chimera constructs were linearized with ScaI. 72 h after transfection, the cells were transferred to Geneticin-containing medium (G418, 1 mg/ml; Life Technologies, Inc.). The geneticin-resistant cells were checked by fluorescence-activated cell sorter analysis for Fcgamma R expression using the monoclonal antibody 2.4G2 (31), and cells were cloned.

Detection of Tyrosine Phosphorylated Proteins

Cells were preincubated at 4 °C with or without 10 µg/ml of 2.4G2 for 15 min and then washed twice with RPMI. 3.5 × 105 cells were then stimulated by F(ab')2 fragments of mouse anti-rat IgG antiserum (50 µg/ml) at 37 °C for the indicated times. As a positive control, 2.4G2 untreated cells were stimulated by F(ab')2 fragments of anti-mouse IgG antibodies (15 µg/ml). At different times, the stimulated cells were lysed with 2% SDS and immediately boiled for 5 min. Proteins were precipitated by acetone for 30 min on ice and pelleted by centrifugation for 5 min at 10,000 × g. The samples were then analyzed on 8% polyacrylamide-SDS gels and transferred on nitrocellulose filters (Schleicher & Schull). Red Ponceau staining of the proteins on the filters allowed verification of the transfer efficiency and the homogeneity between the different lanes. The filters were incubated for 2 h at room temperature in Tris-buffered saline containing 5% bovine serum albumin and then incubated overnight at 4 °C in Tris-buffered saline/5% bovine serum albumin with the anti-phosphotyrosine monoclonal antibody Py20 coupled to HRP (ICN Flow). After washing with Tris-buffered saline containing 0,05% Triton X-100, the filters were incubated for 1 min with the Western blotting Reagent ECL (Amersham Corp.), and chimioluminescence was detected by exposure of the filters to X-Omat films (Kodak) for 30 s to 15 min.

Measurement of IL-2 Secretion

IL-2 release by transfected IIA1.6 B cells (105 cells/well), stimulated for 16 h under the same conditions as for the induction of tyrosine phosphorylations, was determined by monitoring the growth of the IL-2-dependent cell line CTL.L2. For the IL-2 measurement after stimulation without extracellular calcium, either 1 mM of EGTA was added in the standard medium (the viability of the cells was verified with trypan blue) or a calcium-free medium was used (Life Technologies, Inc.). 104 CTL.L2 cells (supernatant free) were cultured for 24 h at 37 °C with supernatants from the activation assays. The cultures were pulse-labeled with 0.5 µCi of [3H]thymidine (25 mCi/mmol, CEA, Gif-sur-Yvette, France) for the last 6 h of the culture period before harvesting the cells using a multiple cell harvester (Osi, Paris, France). The incorporated thymidine was detected by scintillation counting. The IL-2 secreted by mutant chimeras was compared with the IL-2 secreted, during the same experiment, by the same cells after stimulation of endogenous membrane IgG. The values obtained with supernatants of anti-IgG-stimulated cells were ranging from 2 × 104 to 8 × 104 cpm depending of the clones. To compare all the clones, the values were therefore normalized on mIgG stimulation, which represents the maximum of stimulation.

Measurement of Intracellular Calcium Concentrations

Digital calcium imaging experiments were performed on fura-2 (Molecular Probes Eugene, OR) loaded cells (0.25 µM 15 min at 37 °C in culture medium, 106 cells/ml) as previously described (18). The averages of intracellular calcium changes were calculated with 50-100 single cell measurements.


RESULTS

The intracellular signaling activity of mIg-associated subunits, Ig-alpha and Ig-beta , was analyzed by expressing, in the B cell line IIA1.6, chimeras fusing the cytoplasmic domain of either Ig-alpha or Ig-beta to the extracellular and transmembrane domains of Fcgamma RII. Both chimeras activated tyrosine kinases (Fig. 1a), but only Ig-alpha chimeras (c.Ig-alpha ) stimulation induced intracellular calcium modifications composed of an initial release from intracellular stores followed by an extracellular calcium influx, whereas Ig-beta chimeras (c.Ig-beta ) stimulation triggered an oscillatory release of calcium from intracellular stores (Fig. 1b) (18). Interestingly, only Ig-alpha chimeras, as well as endogenous mIg, were efficient to induce the secretion of cytokines.


Fig. 1. Ig-alpha and Ig-beta cytoplasmic tails activate distinct signaling pathways. a, chimeras were preincubated with the rat anti-FcR antibody 2.4G2 (10 µg/ml), and the stimulation was triggered by the F(ab)'2 antiserum mouse anti-rat (50 µg/ml) for the indicated times. After separation on SDS-8% polyacrylamide gels, the proteins were immunoblotted with the horseradish peroxidase-coupled anti-phosphotyrosine monoclonal antibody Py20. The arrow indicates the phosphoproteins induced by the cross-linking of mIg, which peak at 2 min. b, arithmetic average of intracellular calcium concentration measurements at the single cell level in a standard medium after cross-linking of the Ig-alpha or the Ig-beta chimeras. The arrow indicates the triggering of stimulation. The boxed curve represents an example of a single cell response. c, measurement of IL-2 production after cross-linking of Ig-alpha and Ig-beta chimeras. Cross-linking of Ig-alpha chimeras without extracellular Ca2+ inhibits IL-2 secretion. Chimeras were cross-linked in the same conditions than above overnight at 37 °C in a standard medium containing or not 1 mM EGTA or in a Ca2+ free medium. The IL-2 secretion induced by Ig-alpha chimeras was restored by the addition of 1 mM of Ca2+ in the media. The results were normalized on the mIg responses, which represent the maximum of IL-2 secretion.
[View Larger Version of this Image (42K GIF file)]

The role of calcium influx in B cell signaling was analyzed by measuring IL-2 secretion after stimulation of Ig-alpha chimera or mIgG in conditions that prevented the extracellular calcium influx. Cells expressing c·Ig-alpha were incubated with EGTA to chelate the extracellular calcium or in a calcium free medium. Cross-linking of c.Ig-alpha or of mIgG in the 1 mM EGTA-containing medium (or in calcium-free medium) prevented calcium influx (data not shown) and IL-2 secretion by transfected cells (Fig. 1c). Both signaling events were restored by adding 1 mM CaCl2. Extracellular calcium influx is therefore required for the triggering of cytokine secretion after cross-linking of Ig-alpha chimera or the whole BCR. Moreover, although the cytoplasmic tail of Ig-alpha and Ig-beta both contain an ITAM, only Ig-alpha induced efficient signal transduction. Ig-alpha therefore accounts for the ability of BCR to induce calcium influx and subsequent cell activation events. Peptide sequence of Ig-alpha and Ig-beta ITAM must determine their interactions with specific cytoplasmic effectors that induce either calcium influx and cytokine secretion or calcium oscillatory release.

Requirements of the Conserved ITAM Tyrosine Residues for the Signaling Capacities of Ig-alpha and Ig-beta Tails

To identify the peptide sequences of Ig-alpha and Ig-beta cytoplasmic tails involved in the induction of calcium influx, a mutational analysis was performed by using FcR-based chimeras (see Table I). The cytoplasmic tails of Ig-alpha and Ig-beta were shown to interact with different tyrosine kinases, and the phosphorylation of conserved tyrosine residues constituting their ITAM enhanced these interactions. To evaluate in our model the role of the tyrosine residues present in the ITAM, they were individually mutated to alanine in the cytoplasmic domain of Ig-alpha (c.Ig-alpha A23 and c.Ig-alpha A34) or mutated together in the Ig-beta tail (c.Ig-beta A15,A26). These constructions were stably expressed in IIA1.6 cells, and surface expressions were evaluated by flow cytometry using indirect immunofluorescence (Fig. 2).

Table I.

Chimeric constructs of FcR type II and cytoplasmic domains of Ig-alpha and Ig-beta

Amino acid residues are numbered starting at the first cytoplasmic amino acid residue proximal to the transmembrane domain. The sequences of Ig-alpha and Ig-beta cytoplasmic tails are aligned, and mutations are indicated in bold letters. Tyrosine residues are indicated by arrows.
FcR-Ig-alpha /beta chimeras and mutants Cytoplasmic domains

                            23            34
                            down-arrow             down-arrow
c.Ig-alpha RKRWQNEKFGVDMPDDYEDENLYEGLNLDDCSMYEDISRGLQGTYQDVGNLHIGDAQLEKP
c.Ig-alpha A23 RKRWQNEKFGVDMPDDYEDENLAEGLNLDDCSMYEDISRGLQGTYQDVGNLHIGDAQLEKP
c.Ig-alpha A34 RKRWQNEKFGVDMPDDYEDENLYEGLNLDDCSMAEDISRGLQGTYQDVGNLHIGDAQLEKP
c.Ig-alpha QTAT RKRWQNEKFGVDMPDDYEDENLYEGLNLDQTATYEDISRGLQGTYQDVGNLHIGDAQLEKP
c.Ig-alpha m RKR------Delta -------EDENLYEGLNLDDCSMYEDISRGLQGT--------Delta --------
                            15          26
                      down-arrow          down-arrow
c.Ig-beta RKRDGKAGM________EEDHTYEGLNIDQTATYEDIVTLRTGEVKWSVGEHPGQE
c.Ig-beta A15,A26 RKRDGKAGM________EEDHTAEGLNIDQTATAEDIVTLRTGEVKWSVGEHPGQE
c.Ig-beta DCSM RKRDGKAGM________EEDHTYEGLNIDDCSMYEDIVTLRTGEVKWSVGEHPGQE
c.Ig-beta m RKR--Delta ---________EEDHTYEGLNIDQTATYEDIVTLRTGE-----Delta ------


Fig. 2. Surface expression of Ig-alpha and Ig-beta chimeras in IIA1.6 transfected cells by indirect fluorescence. Cells were incubated with the anti-FcR antibody 24G2 and then with the fluorescein-conjugated mouse anti-rat IgG antiserum (white histograms). The dark histograms represent the control experiments where the cells were only incubated with the fluorescein-coupled antibodies.
[View Larger Version of this Image (23K GIF file)]

The earliest known BCR signaling event is tyrosine kinase activation leading to a cascade of intracellular protein phosphorylations. Our previous results showed that the cytoplasmic domains of Ig-alpha and Ig-beta are able to trigger phosphorylation of similar major intracellular proteins (Fig. 1a). As expected, c.Ig-alpha A23 and c.Ig-alpha A34 or c.Ig-beta A15,A26 were inefficient to trigger tyrosine phosphorylation of intracellular proteins, whereas in control experiments, stimulation of mIg triggered tyrosine phosphorylation in all the transfectant cells (Fig. 3a). The stimulation of these mutated chimeras was also inefficient to induce any changes of the intracellular calcium concentration, as measured at the single cell level by video imaging (Fig. 3b), and they did not trigger IL-2 secretion (Fig. 3c). All the transfected cells were responsive to stimulation via mIg. Ig-alpha and Ig-beta cytoplasmic tails trigger two different signaling pathways, which are therefore both dependent on ITAM tyrosine residues. As shown by others (15, 19, 20, 21), the conserved tyrosines residues are required for the induction of transmembrane signaling through Ig-alpha and Ig-beta . Because both chains activate different signaling pathways, some Ig-alpha or Ig-beta specific amino acids must modulate their signaling activities.


Fig. 3. The mutation of the tyrosine residues in the entire cytoplasmic tail of Ig-alpha (c.Ig-alpha A23 and c.Ig-alpha A34) or Ig-beta (c.Ig-beta A15,A26) prevent the triggering of intracellular signaling events. Chimeras were cross-linked in the same conditions as before. a, tyrosine phosphorylations of intracellular proteins after cross-linking of chimeras (anti-chimeras) or endogenous mIg (anti-IgG). b, measurement of intracellular Ca2+ concentrations at the single cell level after cross-linking of mutant chimeras (arithmetic averages). The arrows indicate the triggering of stimulation. The dotted arrows indicate the control-stimulation experiments where the endogenous mIg were cross-linked. Boxed curves represent examples of a single cell response. c, IL-2 secretion by the cells expressing chimeras. Chimeras were cross-linked as before (anti-chimera), and in the control experiments, mIg were cross-linked with 15 µg/ml of F(ab)'2 fragments of rabbit anti-mouse IgG (anti-IgG). The results presented here are the means of three experiments done in duplicate and are normalized on the mIg responses, which represent the maximum of IL-2 secretion.
[View Larger Version of this Image (24K GIF file)]

Four Amino Acids in the ITAM Determine the Signaling Capabilities of Ig-alpha and Ig-beta Cytoplasmic Domains

One major difference between Ig-alpha and Ig-beta ITAM consists of four amino acids preceding the second tyrosine of the motifs. The peptide sequence DCSM is present in Ig-alpha , whereas Ig-beta contains the sequence QTAT. This difference has been related to the specific binding of src family kinases to the cytoplasmic tails of Ig-alpha or Ig-beta . In a nonphosphorylated status, only the molecules bearing the four amino acids DCSM bind the tyrosine kinase fyn (14). The role of these four amino acids in the signaling activity of Ig-alpha and Ig-beta was investigated by expressing two chimeras containing a switch of the sequences QTAT versus DCSM in Ig-alpha and Ig-beta cytoplasmic tails (c.Ig-alpha QTAT and c.Ig-beta DCSM) (see Table I and Fig. 2). The cross-linking of c.Ig-beta DCSM triggered the phosphorylation of numerous intracellular proteins and an extracellular calcium influx leading to IL-2 secretion (Fig. 4, a, b, and c). The exchange of QTAT by DCSM inside the entire Ig-beta cytoplasmic domain was therefore sufficient to convert the transducing phenotype of Ig-beta in that of Ig-alpha tail. Because the cross-linking of c.Ig-beta was not able to trigger a calcium influx, the capacity of c.Ig-alpha and c.Ig-beta DCSM to trigger a calcium influx is probably determined by the presence of the DCSM polypeptide sequence in their cytoplasmic tail. In contrast, the conversion of the DCSM sequence into QTAT in the Ig-alpha tail did not prevent the triggering of calcium influx and tyrosine kinase activation (Fig. 4, a, b, and c). In all these experiments, the transfectant cells were responsive to anti-IgG. The results obtained with the switching mutants showed that the ability of Ig-beta to trigger different intracellular events may be modulated by amino acids located between the conserved ITAM residues, whereas the similar switch (QTAT) in the entire Ig-alpha cytoplasmic tail does not affect its signaling capacity. The conformation induced by the peptide sequences surrounding Ig-beta ITAM must be important to induce its interactions with specific intracellular effectors.


Fig. 4. The inversion of the peptide sequences DCSM and QTAT change the transducing capacities of Ig-alpha and Ig-beta cytoplasmic domains. a, tyrosine kinase activation after cross-linking of the two chimeras containing the inversion (c.Ig-beta DCSM and c.Ig-alpha QTAT) in the same conditions than before. b, intracellular calcium measurement after cross-linking of the chimeras. As before, the arrows show the addition of the second antibody to cross-link the chimeras, and the dotted arrows indicate the addition of F(ab)'2 fragments of rabbit anti-mouse IgG. Boxed curves show examples of a single cell response. c, IL-2 secretion after cross-linking of the chimeras or after cross-linking of mIg for control experiments. The measurements were done in the same conditions as in Fig. 3.
[View Larger Version of this Image (39K GIF file)]

The Activity of Ig-beta ITAM Is Regulated by Flanking Sequences

The sequences flanking the two motifs are different between Ig-alpha and Ig-beta cytoplasmic tails. To test whether flanking sequences affect the signaling capacities of ITAMs, chimeras containing isolated Ig-alpha or Ig-beta motifs (c.Ig-alpha m and c.Ig-beta m; Table I) were expressed in IIA1.6 cells (Fig. 2). The stimulation of c.Ig-alpha m induced tyrosine phosphorylation of several intracellular substrates similar to those induced by the cross-linking of c.Ig-alpha , with a maximum of phosphorylation intensity after 1 min of stimulation (Fig. 5a). The pattern of calcium signaling obtained after cross-linking of c.Ig-alpha m was similar to the pattern obtained after stimulation of c.Ig-alpha , comprising a release of calcium from the intracellular stores and an influx of extracellular calcium (Fig. 5b). This calcium response triggered by the cross-linking of c.Ig-alpha m was followed by later events of signals transduction, as measured by IL-2 secretion (Fig. 5c). Thus, when isolated, the Ig-alpha ITAM was as efficient as the entire Ig-alpha cytoplasmic tail and as the whole BCR in triggering cytokine production. The ITAM of Ig-alpha is therefore fully functional inside the entire Ig-alpha tail environment, and it is not regulated directly by its flanking sequences.


Fig. 5. Ig-alpha ITAM functions as the entire cytoplasmic tail of Ig-alpha , whereas the motif of Ig-beta does not function as the entire intracellular domain of Ig-beta . a, intracellular protein phosphorylation induced by the cross-linking of the chimeras for the indicated times. The cells were also stimulated by their endogenous mIgG (arrow). b, measurement of intracellular calcium concentration after cross-linking of chimeras containing the Ig-alpha or Ig-beta ITAM (c.Ig-alpha m and c.Ig-beta m, respectively). The arrows indicate the triggering of the stimulation, and the boxed curves represent an example of a single cell response. c, stimulation of both chimeras triggered IL-2 secretion. The cells all produced IL-2 after cross-linking of mIgG. This experiment was done under the same conditions as described in the legend to Figs. 3 and 4.
[View Larger Version of this Image (39K GIF file)]

Surprisingly, the isolated Ig-beta ITAM had different signaling abilities than the entire cytoplasmic tail of Ig-beta . In contrast to intracellular calcium oscillations induced by Ig-beta chimeras, the cross-linking of c.Ig-beta m triggered a complete calcium response composed of an initial calcium release from intracellular stores followed by an extracellular calcium influx (Fig. 5b), like the cross-linking of mIg, c.Ig-alpha , or c.Ig-alpha m. Moreover, the stimulation of c.Ig-beta m was very efficient in inducing IL-2 secretion (Fig. 5c). In contrast, no clear differences of phosphoproteins were detected after cross-linking of c.Ig-beta m or c.Ig-beta , whereas the maximum intensities of the phosphorylations were respectively observed after 2 and 1 min of cross-linking (Figs. 1a and 5a). Thus, the isolated Ig-beta ITAM and the entire cytoplasmic tail of Ig-beta are both able to activate tyrosine kinases but differ in terms of calcium signaling and triggering of IL-2 secretion.

These results show that the two isolated Ig-alpha and Ig-beta ITAMs are able to trigger the same intracellular events leading to cytokine production and that the unconserved environment of an ITAM can regulate the signaling activity of this kind of tyrosine-based activating motifs.


DISCUSSION

Stimulation of BCR triggers intracellular events such as protein kinase activation and increase of intracellular calcium concentration resulting in cell activation. In the present work, we evaluated the relative contributions of different domains of Ig-alpha and Ig-beta cytoplasmic tails in B cell signaling. The cytoplasmic domain of Ig-alpha , and more specifically its ITAM, reflects the transducing capacities of the whole BCR in terms of phosphoproteins induction, calcium mobilization, and IL-2 secretion, which is dependent on the triggering of a calcium influx. In contrast, Ig-beta ITAM activity is modulated by amino acids located between the conserved residues and by the ITAM flanking sequences, although the signaling capacities of both ITAMs require conserved tyrosine residues.

The transducing events triggered by Ig-alpha ITAM are similar to those triggered by the entire intracellular domain of Ig-alpha and by the whole BCR. In this cascade of intracellular signaling events, the triggering of extracellular calcium influx is a crucial step of B cell activation, which may be inhibited by the cross-linking of mIg with FcR for IgG (22, 23, 24). In addition, chelation of extracellular calcium with EGTA inhibits the triggering of both calcium influx and lymphokine secretion after stimulation of either BCR or Ig-alpha chimeras (Fig. 1c). Furthermore, Ig-beta chimera stimulation did not efficiently induce lymphokine secretion, although this molecule triggered intracellular tyrosine phosphorylation and oscillatory releases of intracellular calcium stores without extracellular influx (18). It has been shown that in T cells, IgM-Ig-beta and CD8-Ig-beta chimeras were able to trigger IL-2 after cross-linking (20, 17), but T cells could lack an intracellular effector that regulates Ig-beta activity in B cells. The triggering of late B cell activation events as assessed by lymphokine secretion is therefore based on the signaling capacities of Ig-alpha cytoplasmic domain, which may be reduced to its ITAM.

The Ig-alpha and Ig-beta cytoplasmic tails therefore triggered distinct intracellular events, whereas, strikingly, the isolated ITAMs have the same efficient transducing capacities. Stimulation of both chimeras containing the isolated motifs induced the phosphorylation of the same intracellular substrates and triggered both calcium influx and IL-2 secretion. These results are consistent with data obtained with similar µCD8-based chimeras containing the isolated ITAM of Ig-alpha or Ig-beta (25). They showed that cross-linking of these chimeras triggered the same protein tyrosine phosphorylations and calcium mobilization and induced the interaction of the motifs with the same kinases lyn, fyn, and syk. Another study has also shown that phosphorylated ITAMs of Ig-alpha or Ig-beta have similar abilities to interact with fyn in vitro (14). The phosphorylation of the ITAM tyrosine therefore seems to be a crucial step to induce the transducing cascade because the mutation of ITAM-conserved tyrosine residues totally abolished the signaling capabilities of both Ig-alpha and Ig-beta cytoplasmic tails (Fig. 3; Refs. 15 and 19, 20, 21), perhaps by preventing the interaction with fyn or with other kinase(s). Therefore, as already described, the ITAM-tyrosine residues are required to give to Ig-alpha and Ig-beta their transducing capabilities.

The specificity of Ig-alpha and Ig-beta tails to trigger different signaling events seems determined by nonconserved sequences between the cytoplasmic tails of Ig-alpha and Ig-beta . One of the differences between the two ITAM-amino acid sequences is constituted of four amino acids located between the conserved tyrosine residues (DCSM in Ig-alpha and QTAT in Ig-beta ). Our results show that this difference of four amino acids do not seem to play a role in the transduction events triggered by the isolated motifs (Fig. 5), but it is important when the motifs are examined in their entire cytoplasmic environment. Indeed, the conversion of the four amino acids QTAT into DCSM in the Ig-beta cytoplasmic tail changed the signaling activity of Ig-beta into those of Ig-alpha (Fig. 4), perhaps by enhancing the basal level of fyn associated with the chimera, because only the DCSM-bearing ITAMs were able to interact with fyn in vitro (14). In contrast, when the amino acids DCSM were changed into QTAT in Ig-alpha cytoplasmic tail, the transducing capacities of Ig-alpha were not switched, showing that QTAT is necessary but not sufficient to inactivate the calcium influx and/or to activate calcium oscillations. These results indicate that there are other amino acids inside or outside the Ig-beta ITAM that also regulate its signaling capacities.

The ITAM of Ig-beta , in contrast to the entire cytoplasmic domain of Ig-beta , is fully efficient to trigger intracellular events leading to lymphokine secretion. This indicates that ITAM flanking sequences regulate the activity of the Ig-beta ITAM. These sequences are inefficient, however, when the four amino acids QTAT are replaced by DCSM (Fig. 4). This suggests that other amino acids that differ between the two motifs, like the four amino acids located before the first tyrosine of the two motifs (DENL in Ig-alpha and EDHT in Ig-beta ), may play a role in the regulation capacity of flanking regions of Ig-beta ITAM. This sequence could regulate the Ig-beta ITAM by interacting with intracellular proteins, like the two unidentified p40 and p42 phosphoproteins (9), which bind specifically to Ig-beta . Two nonexclusive models may be proposed to account for the specificity of Ig-alpha and Ig-beta intracellular signaling. First, the nonconserved sequences located inside or outside the ITAM induce conformational modifications, which modulate the affinity of cytoplasmic effectors for conserved tyrosine residues located in the ITAM. Second, each domain of the cytoplasmic tails of Ig-alpha and Ig-beta (QTAT, DCSM, or flanking sequences) may interact with distinct intracellular effectors, which are specifically recruited by receptor aggregation and thus determine the activation of different intracellular signaling pathways. However, the fact that the deletion of one of the flanking sequences is enough to allow Ig-beta to trigger IL-2 secretion after stimulation (data not shown) supports a conformational role for the flanking sequences.

The signaling activity of the BCR-associated subunits can be regulated by cross-linking of mIg with FcR (22, 26) involving the phosphatase PTP1C, which acts as a trans-regulator of the Ig-alpha /Ig-beta ITAM activity (27). Our results show that QTAT or flanking sequences regulate Ig-beta ITAM signaling activities, meaning that these activating motifs can be regulated in a cis-position. It remains to establish what is the function of these sequences in the whole BCR complex and whether cytoplasmic ligands of Ig-beta cytoplasmic tail may regulate the signaling activity carry out by Ig-alpha cytoplasmic tail, as is suggested by results showing that mIg stimulation of spleen B cells could trigger calcium oscillations (28). During B cell activation and differentiation, BCR composition may vary because heterodimers with cytoplasmic deleted isoforms of Ig-alpha or Ig-beta have been reported (29, 30). The heterodimers that contain one of these deleted forms therefore probably have the signaling capacities of either Ig-alpha or Ig-beta . Variations in cytosol composition could also determine the activation of one chain more than the other or could trigger different events depending on the effectors present in the cells, like for Ig-beta chimeras in T cells that are able to induce IL-2 secretion (17, 20). The analysis of relative signaling capacities of Ig-alpha and Ig-beta and their peptide sequence requirement is a first step in understanding BCR signaling events during the different stages of B cell differentiation or activation.


FOOTNOTES

*   This work was supported by the Institut National pour la Santé et la Recherche Médicale and the Institut Curie. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   Supported by a fellowship from the Ministère de la Recherche et des Techniques and the Association de la Recherche contre le Cancer.
   Address correspondence to: CJF 95-01, Institut Curie, 12 rue Lhomond, 75231 Paris cedex 05, France. Tel.: 33-1-42-34-63-88; Fax: 33-1-42-34-63-82; E-mail: bonnerot{at}curie.fr.
''   Present address: Duke University, Durham, NC.
1   The abbreviations used are: BCR, B cell antigen receptor(s); mIg, membrane immunoglobulin; IL-2, interleukin-2; FcR, Fcgamma RII; m, motif.

Acknowledgments

We thank D. Lankar and M. A. Marloie for excellent technical participation and Dr. M. Partiseti and Dr. J. Verheugen for help in the calcium studies. We thank Dr. S. Amigorena and Dr. J. Salamero for advice during manuscript preparation.


REFERENCES

  1. Gold, M. R., Matsuuchi, L., Kelly, R. B., DeFranco, A. L. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 3436-3440 [Abstract/Free Full Text]
  2. Campbell, K. S., Cambier, J. C. (1990) EMBO J. 9, 441-448 [Medline] [Order article via Infotrieve]
  3. Yamanashi, Y., Kakiuchi, T., Mizuguchi, J., Yamamoto, T., Toyoshima, K. (1991) Science 251, 192-194 [Abstract/Free Full Text]
  4. Burkhardt, A. L., Brunswick, M., Bolen, J. B., Mond, J. J. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 7410-7414 [Abstract/Free Full Text]
  5. Lin, J., Justement, L. B. (1992) J. Immunol. 149, 1548-1555 [Abstract]
  6. Campbell, M. A., Sefton, B. M. (1992) Mol. Cell. Biol. 12, 2315-2321 [Abstract/Free Full Text]
  7. Hutchcroft, J. E., Harrison, M. L., Geahlen, R. L. (1992) J. Biol. Chem. 267, 8613-8619 [Abstract/Free Full Text]
  8. Yamada, T., Taniguchi, T., Yang, C., Yasue, S., Saito, H., Yamamura, H. (1993) Eur. J. Biochem. 213, 455-459 [Medline] [Order article via Infotrieve]
  9. Clark, M. R., Campbell, K. S., Kazlauskas, A., Johnson, S. A., Hertz, M., Potter, T. A., Pleiman, C., Cambier, J. C. (1992) Science 258, 123-126 [Abstract/Free Full Text]
  10. Baixeras, E., Kroemer, G., Cuende, E., Marquez, C., Bosca, L., Martinez, J. E. A., Martinez, A.-C. (1993) Immunol. Rev. 132, 5-47 [CrossRef][Medline] [Order article via Infotrieve]
  11. Gelfand, E. W., Cheung, R. K., Mills, G. B., Grinstein, S. (1988) Eur. J. Immunol. 18, 917-922 [Medline] [Order article via Infotrieve]
  12. Dennis, G. J., Mizuguchi, J., McMillan, V., Finkelman, F. D., Ohara, J., Mond, J. J. (1987) J. Immunol. 138, 4307-4312 [Abstract]
  13. Reth, M. (1989) Nature 338, 383-384 [Medline] [Order article via Infotrieve]
  14. Clark, M. R., Johnson, S. A., Cambier, J. C. (1994) EMBO J. 13, 1911-1919 [Medline] [Order article via Infotrieve]
  15. Sanchez, M., Misulovin, Z., Burkhardt, A. L., Mahajan, S., Costa, T., Franke, R., Bolen, J. B., Nussenzweig, M. (1993) J. Exp. Med. 178, 1049-1055 [Abstract/Free Full Text]
  16. Kim, K. M., Alber, G., Weiser, P., Reth, M. (1993) Eur. J. Immunol. 23, 911-916 [Medline] [Order article via Infotrieve]
  17. Taddie, J. A., Hurley, T. R., Hardwick, B. S., Sefton, B. M. (1994) J. Biol. Chem. 269, 13529-13535 [Abstract/Free Full Text]
  18. Choquet, D., Ku, G., Cassard, S., Malissen, B., Korn, H., Fridman, W. H., Bonnerot, C. (1994) J. Biol. Chem. 269, 6491-6497 [Abstract/Free Full Text]
  19. Flaswinkel, H., Reth, M. (1994) EMBO J. 13, 83-89 [Medline] [Order article via Infotrieve]
  20. Burkhardt, A. L., Costa, T., Misulovin, Z., Stealy, B., Bolen, J. B., Nussenzweig, M. (1994) Mol. Cell. Biol. 14, 1095-1103 [Abstract/Free Full Text]
  21. Williams, G. T., Peaker, C. J. G., Patel, K. J., Neuberger, M. S. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 474-478 [Abstract/Free Full Text]
  22. Amigorena, S., Bonnerot, C., Drake, J. R., Choquet, D., Hunziker, W., Guillet, J.-G., Webster, P., Sautes, C., Mellman, I., Fridman, W. H. (1992) Science 256, 1808-1812 [Abstract/Free Full Text]
  23. Choquet, D., Partiseti, M., Amigorena, S., Bonnerot, C., Fridman, W. H., Korn, H. (1993) J. Cell. Biol. 121, 355-363 [Abstract/Free Full Text]
  24. Diegel, M. L., Rankin, B. M., Bolen, J. B., Dubois, P. M., Kiener, P. A. (1994) J. Biol. Chem. 269, 11409-11416 [Abstract/Free Full Text]
  25. Law, D. A., Chan, V. W. F., Datta, S. K., DeFranco, A. L. (1993) Curr. Biol. 3, 645-657
  26. Muta, T., Kurosaki, T., Misulovin, Z., Sanchez, M., Nussenzweig, C., Ravetch, J. V. (1994) Nature 368, 70-73 [CrossRef][Medline] [Order article via Infotrieve]
  27. D'Ambrosio, D., Hippen, K. H., Minskoff, S. A., Mellman, I., Pani, G., Siminovitch, K. A., Cambier, J. C. (1995) Science 268, 293-297 [Abstract/Free Full Text]
  28. Wilson, H. A., Greenblatt, D., Poenie, M., Finkelman, F. D., Tsien, R. (1987) J. Exp. Med. 166, 601-606 [Abstract/Free Full Text]
  29. Friedrich, R. J., Campbell, K. S., Cambier, J. C. (1993) J. Immunol. 150, 2814-2822 [Abstract]
  30. Ishihara, K., Wood, W. J., Jr., Wall, R., Sakaguchi, N., Michnoff, C., Tucker, P. W., Kincade, P. W. (1993) J. Immunol. 150, 2253-2262 [Abstract]
  31. Unkeless, X. (1979) J. Exp. Med. 150, 580-596 [Abstract/Free Full Text]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JEMHome page
A. Gazumyan, A. Reichlin, and M. C. Nussenzweig
Ig{beta} tyrosine residues contribute to the control of B cell receptor signaling by regulating receptor internalization
J. Exp. Med., July 10, 2006; 203(7): 1785 - 1794.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Pike and M. J. H. Ratcliffe
Dual Requirement for the Ig{alpha} Immunoreceptor Tyrosine-Based Activation Motif (ITAM) and a Conserved Non-Ig{alpha} ITAM Tyrosine in Supporting Ig{alpha}{beta}-Mediated B Cell Development
J. Immunol., February 15, 2005; 174(4): 2012 - 2020.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. M. Fuentes-Panana, G. Bannish, N. Shah, and J. G. Monroe
Basal Ig{alpha}/Ig{beta} Signals Trigger the Coordinated Initiation of Pre-B Cell Antigen Receptor-Dependent Processes
J. Immunol., July 15, 2004; 173(2): 1000 - 1011.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Pike, S. Iacampo, J. E. Friedmann, and M. J. H. Ratcliffe
The Cytoplasmic Domain of Ig{alpha} Is Necessary and Sufficient to Support Efficient Early B Cell Development
J. Immunol., February 15, 2004; 172(4): 2210 - 2218.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. van Lent, K. C. Nabbe, P. Boross, A. B. Blom, J. Roth, A. Holthuysen, A. Sloetjes, S. Verbeek, and W. van den Berg
The Inhibitory Receptor Fc{gamma}RII Reduces Joint Inflammation and Destruction in Experimental Immune Complex-Mediated Arthritides Not Only by Inhibition of Fc{gamma}RI/III but Also by Efficient Clearance and Endocytosis of Immune Complexes
Am. J. Pathol., November 1, 2003; 163(5): 1839 - 1848.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Kabak, B. J. Skaggs, M. R. Gold, M. Affolter, K. L. West, M. S. Foster, K. Siemasko, A. C. Chan, R. Aebersold, and M. R. Clark
The Direct Recruitment of BLNK to Immunoglobulin {alpha} Couples the B-Cell Antigen Receptor to Distal Signaling Pathways
Mol. Cell. Biol., April 15, 2002; 22(8): 2524 - 2535.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. Bannish, E. M. Fuentes-Panana, J. C. Cambier, W. S. Pear, and J. G. Monroe
Ligand-independent Signaling Functions for the B Lymphocyte Antigen Receptor and Their Role in Positive Selection during B Lymphopoiesis
J. Exp. Med., November 26, 2001; 194(11): 1583 - 1596.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Kraus, L. I. Pao, A. Reichlin, Y. Hu, B. Canono, J. C. Cambier, M. C. Nussenzweig, and K. Rajewsky
Interference with Immunoglobulin (Ig){alpha} Immunoreceptor Tyrosine-based Activation Motif (ITAM) Phosphorylation Modulates or Blocks B Cell Development, Depending on the Availability of an Ig{beta} Cytoplasmic Tail
J. Exp. Med., August 20, 2001; 194(4): 455 - 470.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. Kouro, K. Nagata, S. Takaki, S. Nisitani, M. Hirano, M. I. Wahl, O. N. Witte, H. Karasuyama, and K. Takatsu
Bruton's tyrosine kinase is required for signaling the CD79b-mediated pro-B to pre-B cell transition
Int. Immunol., April 1, 2001; 13(4): 485 - 493.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. Lankar, V. Briken, K. Adler, P. Weiser, S. Cassard, U. Blank, M. Viguier, and C. Bonnerot
Syk Tyrosine Kinase and B Cell Antigen Receptor (BCR) Immunoglobulin-alpha Subunit Determine BCR-mediated Major Histocompatibility Complex Class II-restricted Antigen Presentation
J. Exp. Med., September 7, 1998; 188(5): 819 - 831.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Cassard, J. Salamero, D. Hanau, D. Spehner, J. Davoust, W. H. Fridman, and C. Bonnerot
A Tyrosine-Based Signal Present in Ig {alpha} Mediates B Cell Receptor Constitutive Internalization
J. Immunol., February 15, 1998; 160(4): 1767 - 1773.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
Y.-M. Teh and M. S. Neuberger
The Immunoglobulin (Ig)alpha and Igbeta Cytoplasmic Domains Are Independently Sufficient to Signal B Cell Maturation and Activation in Transgenic Mice
J. Exp. Med., May 19, 1997; 185(10): 1753 - 1758.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cassard, S.
Right arrow Articles by Bonnerot, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cassard, S.
Right arrow Articles by Bonnerot, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement